The Assessment of Disability Related to Vision Performance-Based Measure in Diabetic Retinopathy

• Published in: American journal of ophthalmology 2010-05, Vol.149 (5), p.852-860.e1
• Main Authors: Warrian, Kevin J, Lorenzana, Luciano L, Lankaranian, Dara, Dugar, Jyoti, Wizov, Sheryl S, Spaeth, George L
• Format: Article
• Language: English
• Subjects: Biological and medical sciences; Cataracts; Colleges & universities; Comorbidity; Contrast Sensitivity - physiology; Cross-Sectional Studies; Diabetes. Impaired glucose tolerance; Diabetic retinopathy; Diabetic Retinopathy - diagnosis; Disability Evaluation; Endocrine pancreas. Apud cells (diseases); Endocrinopathies; Etiopathogenesis. Screening. Investigations. Target tissue resistance; Eyes & eyesight; Family medical history; Female; Health sciences; Humans; International relations; Male; Medical imaging; Medical sciences; Mental health; Methods; Middle Aged; Miscellaneous; Ophthalmology; Prospective Studies; Quality of Life; Questionnaires; Retinopathies; Review boards; Sickness Impact Profile; Surveys and Questionnaires; Vision Disorders - diagnosis; Vision, Binocular - physiology; Visual Acuity - physiology; Visually Impaired Persons
• ISSN: 0002-9394; 1879-1891
• DOI: 10.1016/j.ajo.2009.12.028

Purpose To validate a third-generation performance-based measure of visual function titled “Assessment of Disability Related to Vision” (ADREV) in a study population of patients with diabetic retinopathy. Design Prospective, cross-sectional study. Methods Patients with nonproliferative or proliferative diabetic retinopathy, free from ocular comorbidity, were recruited from a single institute and completed the ADREV, the 25-Item National Eye Institute Visual Functioning Questionnaire (VFQ-25), and a clinical ophthalmic examination. Correlation, regression, and bootstrap analysis were conducted to determine the relationship between ADREV scoring and each of the study's clinical and self-report measures of visual ability, while controlling for potential confounders. Results Ninety-one patients with diabetic retinopathy completed the study and analysis showed that the ADREV total and subscale scores shared a stronger relationship with the clinical measures of visual function than did the VFQ total and subscale scores. Regression analysis revealed that binocular visual acuity, contrast sensitivity, and better eye visual field were the best predictors of ADREV performance. Conclusions The ADREV performance measure is a valid instrument for the assessment of disability related to vision in patients with diabetic retinopathy. Furthermore, the assessments provided by ADREV were more related to traditional clinical indicators of visual impairment than were the results of the self-report measure, specifically the VFQ-25.